메뉴 건너뛰기




Volumn 61, Issue 11, 2008, Pages 687-691

Macrolactin S, a new antibacterial agent with FabG-inhibitory activity from Bacillus sp. AT28

Author keywords

Antibacterial; Bacillus; FabG; Macrolactin; Staphylococcus aureus

Indexed keywords

ANTIBIOTIC AGENT; MACROLACTIN B; MACROLACTIN S; UNCLASSIFIED DRUG;

EID: 58849102153     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.1038/ja.2008.98     Document Type: Article
Times cited : (30)

References (21)
  • 1
    • 0035338328 scopus 로고    scopus 로고
    • Bacterial fatty-acid biosynthesis: A genomic-driven target for antibacterial drug discovery
    • Payne DJ, Warren PV, Holmes DJ, Ji Y, Lonsdale JT. Bacterial fatty-acid biosynthesis: a genomic-driven target for antibacterial drug discovery. Drug Discov Today 6: 537-544 (2001)
    • (2001) Drug Discov Today , vol.6 , pp. 537-544
    • Payne, D.J.1    Warren, P.V.2    Holmes, D.J.3    Ji, Y.4    Lonsdale, J.T.5
  • 2
    • 0034804919 scopus 로고    scopus 로고
    • Lipid biosynthesis as a target for antibacterial agents
    • Heath RJ, White SW, Rock CO. Lipid biosynthesis as a target for antibacterial agents. Prog Lipid Res 40: 467-497 (2001)
    • (2001) Prog Lipid Res , vol.40 , pp. 467-497
    • Heath, R.J.1    White, S.W.2    Rock, C.O.3
  • 3
    • 0034780806 scopus 로고    scopus 로고
    • Bacterial fatty acid biosynthesis: Targets for antibacterial drug discovery
    • Campbell JW, Cronan Jr JE. Bacterial fatty acid biosynthesis: targets for antibacterial drug discovery. Annu Rev Microbiol 55: 305-332 (2001)
    • (2001) Annu Rev Microbiol , vol.55 , pp. 305-332
    • Campbell, J.W.1    Cronan Jr, J.E.2
  • 4
    • 3843101649 scopus 로고    scopus 로고
    • Evaluation of epigallocatechin gallate and related plant polyphnols as inhibitors of the FabG and FabI reductases of bacterial type II fatty-acid synthase
    • Zhang YM, Rock CO. Evaluation of epigallocatechin gallate and related plant polyphnols as inhibitors of the FabG and FabI reductases of bacterial type II fatty-acid synthase. J Biol Chem 279: 30994-31001 (2004)
    • (2004) J Biol Chem , vol.279 , pp. 30994-31001
    • Zhang, Y.M.1    Rock, C.O.2
  • 5
    • 0032490937 scopus 로고    scopus 로고
    • Triclosan targets lipid synthesis
    • McMurry LM, Oethinger M, Levy SB. Triclosan targets lipid synthesis. Nature 394: 531-532 (1998)
    • (1998) Nature , vol.394 , pp. 531-532
    • McMurry, L.M.1    Oethinger, M.2    Levy, S.B.3
  • 6
  • 7
    • 34548593708 scopus 로고    scopus 로고
    • Zheng CJ, Sohn MJ, Lee S, Hong YS, Kwak JH, Kim WG. Cephalochromin, a FabI-directed antibacterial of microbial origin. Biochem Biophys Res Commun 362: 1107-1112 (2007)
    • Zheng CJ, Sohn MJ, Lee S, Hong YS, Kwak JH, Kim WG. Cephalochromin, a FabI-directed antibacterial of microbial origin. Biochem Biophys Res Commun 362: 1107-1112 (2007)
  • 8
    • 24944448678 scopus 로고    scopus 로고
    • Fatty acid synthesis is a target for antibacterial activity of unsaturated fatty acids
    • Zheng CJ, Yoo JS, Lee TG, Cho HY, Kim YH, Kim WG. Fatty acid synthesis is a target for antibacterial activity of unsaturated fatty acids. FEBS Lett 579: 157-162 (2005)
    • (2005) FEBS Lett , vol.579 , pp. 157-162
    • Zheng, C.J.1    Yoo, J.S.2    Lee, T.G.3    Cho, H.Y.4    Kim, Y.H.5    Kim, W.G.6
  • 9
    • 33846811742 scopus 로고    scopus 로고
    • Atromentin and leucomelone, the first Inhibitors specific to enoyl-ACP reductase (FabK) of Streptococcus pneumoniae
    • Zheng CJ, Sohn MJ, Kim WG. Atromentin and leucomelone, the first Inhibitors specific to enoyl-ACP reductase (FabK) of Streptococcus pneumoniae. J Antibiot 59: 808-812 (2007)
    • (2007) J Antibiot , vol.59 , pp. 808-812
    • Zheng, C.J.1    Sohn, M.J.2    Kim, W.G.3
  • 12
    • 0024470551 scopus 로고
    • The macrolactins, a novel class of antiviral and cytotoxic macrolides from a deep-sea marine bacterium
    • Gustafson K, Roman M, Fenical W. The macrolactins, a novel class of antiviral and cytotoxic macrolides from a deep-sea marine bacterium. J Am Chem Soc 111: 7519-7524 (1989)
    • (1989) J Am Chem Soc , vol.111 , pp. 7519-7524
    • Gustafson, K.1    Roman, M.2    Fenical, W.3
  • 13
    • 40549135646 scopus 로고    scopus 로고
    • Lu XL, Xu QZh, Shen YH, Liu XY, Jiao BH, Zhang WD, Ni KY. Macrolactin S, a novel macrolactin antibiotic from marine Bacillus sp. Nat Prod Res 22: 342-347 (2008)
    • Lu XL, Xu QZh, Shen YH, Liu XY, Jiao BH, Zhang WD, Ni KY. Macrolactin S, a novel macrolactin antibiotic from marine Bacillus sp. Nat Prod Res 22: 342-347 (2008)
  • 14
    • 36348999714 scopus 로고    scopus 로고
    • Macrolactins O∼R, glycosylated 24-membered lactones from Bacillus sp. AH159-1
    • Zheng CJ, Lee S, Lee CH, Kim WG. Macrolactins O∼R, glycosylated 24-membered lactones from Bacillus sp. AH159-1. J Nat Prod 70: 1632-1635 (2007)
    • (2007) J Nat Prod , vol.70 , pp. 1632-1635
    • Zheng, C.J.1    Lee, S.2    Lee, C.H.3    Kim, W.G.4
  • 17
    • 0035022073 scopus 로고    scopus 로고
    • Novel macrolactins as antibiotic lactones from a marine bacterium
    • Nagao T, Adachi K, Sakai M, Nishijima M, Sano H. Novel macrolactins as antibiotic lactones from a marine bacterium. J Antibiot 54: 333-339 (2001)
    • (2001) J Antibiot , vol.54 , pp. 333-339
    • Nagao, T.1    Adachi, K.2    Sakai, M.3    Nishijima, M.4    Sano, H.5
  • 19
    • 33746935630 scopus 로고    scopus 로고
    • Yoo JS, Zheng CJ, Lee S, Kwak JH, Kim WG. Macrolactin N, a new peptide deformylase inhibitor produced by Bacillus subtilis. Bioorg Med Chem Lett 16: 4889-1892 (2006)
    • Yoo JS, Zheng CJ, Lee S, Kwak JH, Kim WG. Macrolactin N, a new peptide deformylase inhibitor produced by Bacillus subtilis. Bioorg Med Chem Lett 16: 4889-1892 (2006)
  • 20
    • 33646440995 scopus 로고    scopus 로고
    • 7-O-Malonyl macrolactin A, a new macrolactin antibiotic from Bacillus subtilis active against methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and a small-colony variant of Burkholderia
    • Romero-Tabarez M, Jansen R, Sylla M, Lunsdorf H, Haubler S, Santosa DA, Timmis KN, Molinari G. 7-O-Malonyl macrolactin A, a new macrolactin antibiotic from Bacillus subtilis active against methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and a small-colony variant of Burkholderia. Antimicrobial Agents Chemother 50: 1701-1709 (2006)
    • (2006) Antimicrobial Agents Chemother , vol.50 , pp. 1701-1709
    • Romero-Tabarez, M.1    Jansen, R.2    Sylla, M.3    Lunsdorf, H.4    Haubler, S.5    Santosa, D.A.6    Timmis, K.N.7    Molinari, G.8
  • 21
    • 33744819176 scopus 로고    scopus 로고
    • Inhibition of Plasmodium falciparum fatty acid biosynthesis: Evaluation of FabG, FabZ, and FabI and drug targets for flavonoids
    • Tasdemir D, Lack G, Brun R, Ruedi P, Scapozza L, Perozzo R. Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI and drug targets for flavonoids. J Med Chem 49: 3345-3353 (2006)
    • (2006) J Med Chem , vol.49 , pp. 3345-3353
    • Tasdemir, D.1    Lack, G.2    Brun, R.3    Ruedi, P.4    Scapozza, L.5    Perozzo, R.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.